Dishman Seeks $25 Million For Newly Open China Production Facility
This article was originally published in PharmAsia News
Executive Summary
Dishman Pharmaceuticals and Chemicals is offering its plant in China for sale even as it begins production of intermediates after years of regulatory delays.
Dishman Pharmaceuticals and Chemicals is offering its plant in China for sale even as it begins production of intermediates after years of regulatory delays. The India-based company said it wants to sell the plant for $25 million because it has been a drain on resources during the years it was under construction, which began in 2006. Chairman and Managing Director J.R. Vyas said Dishman began production at the plant two months ago to help recover some of the losses and would continue if it fails to get a suitable price. (Click here for more
)
"Dishman Looking To Sell China Plant To Pare Off Debt" - Business Standard (India) (1/12/2014)